39 Publications (Page 1 of 2)
2020
Hemostatic efficacy of an advanced bipolar sealer in open gynecologic, thoracic, and colectomy procedures: A prospective cohort studySchilder, Jeanne⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Anderson, David⋅Anderson, David⋅Anderson, David⋅Shah, Fatima⋅Shah, Fatima⋅Shah, Fatima⋅Holcomb, Bryan⋅Holcomb, Bryan⋅Holcomb, Bryan⋅Shah, Ahmar⋅Shah, Ahmar⋅Shah, Ahmar⋅Fullarton, Grant⋅Fullarton, Grant⋅Fullarton, Grant⋅Ashraf, Shazad⋅Ashraf, Shazad⋅Ashraf, Shazad⋅Fegan, Scott⋅Fegan, Scott⋅Fegan, Scott⋅Paterson, Hugh⋅Paterson, Hugh⋅Paterson, Hugh⋅Schwiers, Michael L⋅Schwiers, Michael L⋅Schwiers, Michael L⋅Singleton, David W⋅Singleton, David W⋅Singleton, David W⋅Waggoner, Jason R⋅Waggoner, Jason R⋅Waggoner, Jason R⋅Fryrear, Raymond⋅Fryrear, Raymond⋅Fryrear, Raymond⋅Robb, Bruce W⋅Robb, Bruce W and Robb, Bruce WInternational Journal of Surgery Open, vol. 24, pp. 63, 2020.
| Journal Article
2018
Cell Origins of High-Grade Serous Ovarian CancerKim, Jaeyeon⋅Kim, Jaeyeon⋅Kim, Jaeyeon⋅Park, Eun Young⋅Park, Eun Young⋅Park, Eun Young⋅Kim, Olga⋅Kim, Olga⋅Kim, Olga⋅Schilder, Jeanne M⋅Schilder, Jeanne M⋅Schilder, Jeanne M⋅Coffey, Donna M⋅Coffey, Donna M⋅Coffey, Donna M⋅Cho, Chi-Heum⋅Cho, Chi-Heum⋅Cho, Chi-Heum⋅Bast, Robert C⋅Bast, Jr, Robert C and Bast, Jr, Robert CCancers, vol. 10, (no. 11), pp. 433, 2018-Nov-12.
| Journal Article
High-Dose-Rate Brachytherapy (hdr-bt) Following Concurrent Chemoradiotherapy (crt) for Locally Advanced Cervical Cancer: Early Outcomes after Adoption of Mri-Guided Adaptive Volumetric PlanningHinton, Jason D⋅Hinton, Jason D⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Guo, Gordon and Guo, GordonBrachytherapy, vol. 17, (no. 4), pp. S126, July-August 2018.
| Journal Article
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group studyTew, William P⋅Tew, William P⋅Sill, Michael W⋅Sill, Michael W⋅Walker, Joan L⋅Walker, Joan L⋅Secord, Angeles Alvarez⋅Secord, Angeles Alvarez⋅Bonebrake, Albert J⋅Bonebrake, Albert J⋅Schilder, Jeanne M⋅Schilder, Jeanne M⋅Stuckey, Ashley⋅Stuckey, Ashley⋅Rice, Laurel⋅Rice, Laurel⋅Tewari, Krishnansu S⋅Tewari, Krishnansu S⋅Aghajanian, Carol A and Aghajanian, Carol AGynecologic Oncology, vol. 151, (no. 2), pp. 263, November 2018.
| Journal Article
2016
Abstract CT092: A phase II study of neoadjuvant abemaciclib (LY2835219) in postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (neoMONARCH)
Hurvitz, Sara A⋅Schilder, Jeanne Marie⋅Frenzel, Martin and Martín, Miguel
Cancer Research, vol. 76, (no. 14 Supplement), pp. CT092, 2016-07-15. | Journal Article
Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group StudyMonk, Bradley J⋅Monk, Bradley J⋅Sill, Michael W⋅Sill, Michael W⋅Walker, Joan L⋅Walker, Joan L⋅Darus, Christopher J⋅Darus, Christopher J⋅Sutton, Gregory⋅Sutton, Gregory⋅Tewari, Krishnansu S⋅Tewari, Krishnansu S⋅Martin, Lainie P⋅Martin, Lainie P⋅Schilder, Jeanne M⋅Schilder, Jeanne M⋅Coleman, Robert L⋅Coleman, Robert L⋅Balkissoon, Jai⋅Balkissoon, Jai⋅Aghajanian, Carol and Aghajanian, CarolJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 34, (no. 19), pp. 2286, 2016-07-01.
| Journal Article
2015
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyBender, David⋅Bender, David⋅Bender, D.⋅Bender, David⋅Sill, Michael⋅Sill, M.W.⋅Sill, Michael⋅Sill, Michael W⋅Lankes, Heather A⋅Lankes, H.A.⋅Lankes, Heather⋅Lankes, Heather⋅Reyes, H.D.⋅Reyes, Henry D⋅Reyes, Henry⋅Reyes, Henry⋅Darus, Christopher J⋅Darus, Christopher⋅Darus, C.J.⋅Darus, Christopher⋅Delmore, James⋅Delmore, J.E.⋅Delmore, James E⋅Delmore, James⋅Rotmensch, J.⋅Rotmensch, Jacob⋅Rotmensch, Jacob⋅Rotmensch, Jacob⋅Gray, Heidi⋅Gray, H.J.⋅Gray, Heidi⋅Gray, Heidi J⋅Mannel, R.S.⋅Mannel, Robert⋅Mannel, Robert S⋅Mannel, Robert⋅Schilder, Jeanne⋅Schilder, Jeanne M⋅Schilder, Jeanne⋅Schilder, J.M.⋅Hunter, M.I.⋅Hunter, Mark⋅Hunter, Mark⋅Hunter, Mark I⋅McCourt, Carolyn⋅McCourt, C.K.⋅McCourt, Carolyn⋅McCourt, Carolyn K⋅Samuelson, Megan⋅Samuelson, Megan⋅Samuelson, M.I.⋅Samuelson, Megan I⋅Leslie, Kimberly⋅Leslie, Kimberly K⋅Leslie, Kimberly and Leslie, K.K.Gynecologic Oncology, vol. 138, (no. 3), pp. 512, 2015.
| Journal Article
2014
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group StudyDizon, Don S⋅Dizon, Don⋅Sill, Michael⋅Sill, Michael W⋅Schilder, Jeanne M⋅Schilder, Jeanne⋅McGonigle, Kathryn⋅McGonigle, Kathryn F⋅Rahman, Zia⋅Rahman, Zia⋅Miller, David S⋅Miller, David⋅Mutch, David⋅Mutch, David G⋅Leslie, Kimberly K and Leslie, KimberlyGynecologic Oncology, vol. 135, (no. 3), pp. 445, 2014.
| Journal Article
A randomized phase II trial of bevacizumab (BV) plus oral everolimus (EV) versus bevacizumab alone for recurrent or persistent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal cancer (PPC)
Tew, William P⋅Sill, Michael⋅McMeekin, D. Scott⋅Secord, Angeles Alvarez⋅Bonebrake, Albert J⋅Schilder, Jeanne⋅Stuckey, Ashley⋅Rice, Laurel⋅Tewari, Krishnansu Sujata and Aghajanian, Carol
Journal of Clinical Oncology, vol. 32, (no. 15_suppl), pp. 5546, 2014-05-20. | Journal Article
2012
Abstract 4275: PLA2activities in human epithelial ovarian cancer ascites
Xu, Yan⋅Cai, Qingchun⋅Zhao, Zhenwen⋅Antalis, Caryl J⋅Yan, Libo⋅Hamed, Ali H⋅Stehman, Frederick B⋅Schilder, Jeanne M and Priore, Giuseppe Del
Cancer Research, vol. 72, (no. 8 Supplement), pp. 4275, 2012-04-15. | Journal Article
Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer
Cai, Qingchun⋅Zhao, Zhenwen⋅Antalis, Caryl⋅Yan, Libo⋅Del Priore, Giuseppe⋅Hamed, Ali Hassan⋅Stehman, Frederick B⋅Schilder, Jeanne M and Xu, Yan
The FASEB Journal, vol. 26, (no. 8), pp. 3320, August 2012. | Journal Article
Epigenetic Resensitization to Platinum in Ovarian CancerMatei, Daniela E⋅Matei, Daniela⋅Fang, Fang⋅Fang, Fang⋅Shen, Changyu⋅Shen, Changyu⋅Schilder, Jeanne M⋅Schilder, Jeanne⋅Arnold, Alesha⋅Arnold, Alesha⋅Zeng, Yan⋅Zeng, Yan⋅Berry, William A⋅Berry, William A⋅Huang, Tim⋅Huang, Tim H⋅Nephew, Kenneth P and Nephew, KenCancer research, vol. 72, (no. 9), pp. 2205, 2012-May-01.
| Journal Article
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancerHess, Lisa⋅Hess, Lisa⋅Stehman, Frederick⋅Stehman, Frederick B⋅Method, Michael W⋅Method, Michael⋅Weathers, Tess⋅Weathers, Tess⋅Gupta, Paridha⋅Gupta, Paridha⋅Schilder, Jeanne and Schilder, Jeanne MGynecologic Oncology, vol. 127, (no. 3), pp. 568, 2012.
| Journal Article
Patient Recall of Health Care Events and Time to Diagnose a Suspected Ovarian CancerHess, Lisa⋅Hess, Lisa⋅Method, Michael⋅Method, Michael⋅Stehman, Frederick⋅Stehman, Frederick⋅Weathers, Tess⋅Weathers, Tess⋅Gupta, Paridha⋅Gupta, Paridha⋅Schilder, Jeanne and Schilder, JeanneClinical Ovarian and Other Gynecologic Cancer, vol. 5, (no. 1), pp. 23, 2012.
| Journal Article
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group studyAlvarez, Edwin A⋅Alvarez, Edwin⋅Brady, William⋅Brady, William⋅Walker, Joan⋅Walker, Joan L⋅Rotmensch, Jacob⋅Rotmensch, Jacob⋅Zhou, Xun C⋅Zhou, Xun⋅Kendrick, James⋅Kendrick, James E⋅Yamada, S.⋅Yamada, S D⋅Schilder, Jeanne⋅Schilder, Jeanne M⋅Cohn, David⋅Cohn, David E⋅Harrison, Charles R⋅Harrison, Charles⋅Moore, Kathleen N⋅Moore, Kathleen⋅Aghajanian, Carol and Aghajanian, CarolGynecologic Oncology, vol. 129, (no. 1), pp. 27, 2012.
| Journal Article
Symptoms of Pelvic Floor Disorders and Quality of Life Measures in Postoperative Patients With Endometrial Cancer
Nosti, Patrick⋅McDermott, Colleen⋅Schilder, Jeanne⋅Stehman, Frederick and Woodman, Patrick
Clinical Ovarian and Other Gynecologic Cancer, vol. 5, (no. 1), pp. 30, 2012. | Journal Article
The Morphology Index: Predictive value of malignancy among clinicians at various levels of training
Barnsfather, Kris⋅Fitzpatrick, C.⋅Wilson, Jill⋅Linn, Cady⋅Brizendine, Edward and Schilder, Jeanne
Gynecologic Oncology, vol. 127, (no. 1), pp. 97, 2012. | Journal Article
2010
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancerFang, Fang⋅Fang, Fang⋅Balch, Curtis⋅Balch, Curt⋅Schilder, Jeanne⋅Schilder, Jeanne M⋅Breen, Timothy⋅Breen, Timothy⋅Zhang, Shu⋅Zhang, Shu⋅Shen, Changyu⋅Shen, Changyu⋅Li, Lang⋅Li, Lang⋅Kulesavage, Carol⋅Kulesavage, Carol⋅Snyder, Anthony J⋅Snyder, Anthony J⋅Nephew, Kenneth P⋅Nephew, Ken⋅Matei, Daniela E and Matei, Daniela ECancer, vol. 116, (no. 17), pp. 4053, 1 September 2010.
| Journal Article
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology GroupKunos, Charles A⋅Kunos, Charles⋅Sill, Michael W⋅Sill, Michael⋅Buekers, Thomas E⋅Buekers, Thomas⋅Walker, Joan L⋅Walker, Joan⋅Schilder, Jeanne M⋅Schilder, Jeanne⋅Yamada, S.⋅Yamada, S D⋅Waggoner, Steven⋅Waggoner, Steven E⋅Mohiuddin, Mohammed⋅Mohiuddin, Mohammed⋅Fracasso, Paula M and Fracasso, PaulaGynecologic Oncology, vol. 120, (no. 2), pp. 228, 2010.
| Journal Article
2009
Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trialMatei, Daniela⋅Matei, Daniela E⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Sutton, Gregory⋅Sutton, Gregory⋅Perkins, Susan⋅Perkins, Susan⋅Breen, Tim⋅Breen, Tim⋅Quon, Check⋅Quon, Check⋅Sidor, Carolyn and Sidor, CarolynGynecologic Oncology, vol. 115, (no. 1), pp. 96, 2009.
| Journal Article
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group studyFiorica, James⋅Fiorica, James V⋅Blessing, John⋅Blessing, John A⋅Puneky, Louis V⋅Puneky, Louis⋅Alverez Secord, Angeles⋅Secord, Angeles⋅Hoffman, James S⋅Hoffman, James⋅Yamada, S.⋅Yamada, S D⋅Buekers, Thomas E⋅Buekers, Thomas⋅Bell, Jeffrey⋅Bell, Jeffrey⋅Schilder, Jeanne and Schilder, Jeanne MGynecologic Oncology, vol. 115, (no. 2), pp. 289, 2009.
| Journal Article
Indiana University Experience in the Management of Vaginal Cancer
Sinha, Bedatri⋅Stehman, Fredrick⋅Schilder, Jeanne⋅Clark, Lori and Cardenes, Higinia
International Journal of Gynecologic Cancer, vol. 19, (no. 4), pp. 693, 20090400. | Journal Article
Representations of Vaginal Symptoms in Cervical Cancer SurvivorsTornatta, Jennifer M⋅Tornatta, Jennifer⋅Carpenter, Janet⋅Carpenter, Janet S⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Cardenes, Higinia R and Cardenes, HiginiaCancer Nursing, vol. 32, (no. 5), pp. 384, 2009-September/October.
| Journal Article
2008
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsZhang, Shu⋅Zhang, Shu⋅Balch, Curt⋅Balch, Curtis⋅Chan, Michael⋅Chan, Michael W⋅Lai, Hung-Cheng⋅Lai, Hung-Cheng⋅Matei, Daniela E⋅Matei, Daniela⋅Schilder, Jeanne⋅Schilder, Jeanne M⋅Yan, Pearlly⋅Yan, Pearlly S⋅Huang, Tim H⋅Huang, Tim⋅Nephew, Kenneth and Nephew, KenCancer Research, vol. 68, (no. 11), pp. 4320, 20080601.
| Journal Article
Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trialMatei, Daniela⋅Matei, Daniela⋅Matei, Daniela E⋅Emerson, Robert E⋅Emerson, Robert E⋅Emerson, Robert E⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Schilder, Jeanne⋅Menning, Nancy⋅Menning, Nancy⋅Menning, Nancy⋅Baldridge, Lee Ann⋅Baldridge, Lee A⋅Baldridge, Lee Ann⋅Johnson, Cynthia S⋅Johnson, Cynthia S⋅Johnson, Cynthia S⋅Breen, Tim⋅Breen, Tim⋅Breen, Tim⋅McClean, John⋅McClean, John⋅McClean, John⋅Stephens, Doyle⋅Stephens, Doyle⋅Stephens, Doyle⋅Whalen, Charles⋅Whalen, Charles⋅Whalen, Charles⋅Sutton, Gregory⋅Sutton, Gregory and Sutton, GregoryCancer, vol. 113, (no. 4), pp. 732, 2008-Aug-15.
| Journal Article